By Marilyn T. McGoldrick, Esq. Published on March 16, 2015 The anti-nausea medication Zofran, marketed off-label to pregnant women to prevent morning sickness, has been found in recent studies to be associated with an increased risk of birth defects. A study by Dr. Gideon Koren of the The… Read More